Clinical trial results show low-intensity therapy can achieve positive outcomes for certain pediatric leukemia subtypes

Clinical trial results from St. Jude Children’s Research Hospital demonstrate the benefits of using genomics and early treatment response to guide risk classification of children with B-cell acute lymphoblastic leukemia (B-ALL).

Facebook Comments